欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
EL/H/0241/001
药品名称
DEXATON 2 mg/5 ml oral solution
活性成分
Dexamethasone sodium phosphate 2.0 mg/ml
剂型
Oral solution
上市许可持有人
VIANEX S.A Tatoiou str., 18 km Athens-Lamia National Road, 14670, Nea Erithrea, Athens, Greece
参考成员国 - 产品名称
Greece (EL)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 20046/0260 - 0010
Cyprus (CY)
许可日期
2013/01/31
最近更新日期
2024/02/22
药物ATC编码
H02AB02 dexamethasone
申请类型
TypeLevel1：
TypeLevel2：
TypeLevel3：
TypeLevel4：
TypeLevel5：
附件文件下载
Final Product Information
|
Final AR for procedure and common texts _PIL_common_Clean
Date of last change:2024/09/06
Final Product Information
|
Final AR for procedure and common texts _PIL_common_Highlighted
Date of last change:2024/09/06
Final Product Information
|
Final AR for procedure and common texts _SPC_common_Clean
Date of last change:2024/09/06
Final Product Information
|
Final AR for procedure and common texts _SPC_common_Highlighted_1
Date of last change:2024/09/06
Final PL
|
PIL clean_PIL_common_final clean
Date of last change:2024/09/06
Final PL
|
PIL track_PIL_common_Highlighted with eof comments 01_07_2022
Date of last change:2024/09/06
Final SPC
|
SmPC clean_SPC_common_final clean
Date of last change:2024/09/06
Final SPC
|
SmPC track_SPC_common_Highlighted_ with eof comments 07_01_2022
Date of last change:2024/09/06
Final Product Information
|
T_PIL_common_Highlighted with eof comments 01_07_2022
Date of last change:2024/09/06
Final Product Information
|
T_SPC_common_Highlighted_ with eof comments 07_01_2022
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase